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Conventional malaria diagnosis based on microscopy raises serious diﬃculties in weak health systems. Cost-eﬀective and sensitive
rapid diagnostic tests have been recently proposed as alternatives to microscopy. In Equatorial Guinea, a study was conducted to
assess the reliability of a rapid diagnostic test compared to microscopy. The study was designed in accordance with the directives of
the Standards for Reporting Diagnostic Accuracy Initiative (STARD). Peripheral thick and thin ﬁlms for the microscopy diagnosis
and a rapid immunochromatographic test (ICT Malaria Combo Cassette Test) were performed on under ﬁve-year-old children
with malaria suspicion. The ICT test detected Plasmodium spp. infection with a sensitivity of 81.5% and a speciﬁcity of 81.9%
while P. falciparum diagnosis occurred with a sensitivity of 69.7% and a speciﬁcity of 73.7%. The sensitivity of the ICT test
increased with higher parasitemias. The general results showed little concordance between the ICT test and microscopy (kappa
= 0.28, se: 0.04). In Equatorial Guinea, the ICT Malaria Combo Cassette Test has proven to be an acceptable test to detect high
P. falciparum parasitemias. However, the decrease of sensitivity at medium and low parasitemias hampers that ICT can replace
properly performed microscopy at present in the diagnosis of malaria in children.
1.Background
The current malaria control strategies are mainly based
on early diagnosis and a correct treatment of the cases.
These are essential to reduce the fatal outcome of the
disease [1]. However, the weakness of the health systems
in many endemic countries, particularly at the peripheral
level, means that the malaria diagnosis has to be based on
clinical criteria. Taking into account that other infectious
diseases course with signs and symptoms like malaria, a high
percentageofoverdiagnosiscanbeexpectedinatropicalarea
[2–4].
The growing resistance to drugs commonly used for
malaria treatment (chloroquine, quinine, and sulphadoxine-
pyrimethamine), due to their abusive use in the past, and the
arrival of artemisinin-based combination therapies (ACTs),
which are more expensive than the former, mean that the
methods to diagnose malaria are once again back in the
spotlight. Microscopy and the use of rapid diagnostic tests
(RDTs) are currently considered to be the two diagnostic
procedures with the greatest impact on controlling malaria
[5].
Microscopy can be a highly useful diagnostic tool, as
in expert hands it can detect up to 50 parasites per µl2 Malaria Research and Treatment
(0.001% parasitemia) and identify the plasmodia in 98% of
the cases [6, 7]. However, this procedure is not simple and
time consuming, requiring the sample to be stained quickly
to maintain its reliability. It also demands well-trained and
motivated human resources, along with properly maintained
equipment [8]. Thus, there are several evidences of the low
diagnostic capacity of microscopy services under real ﬁeld
conditions [9–12].
Therefore, the availability of cost eﬀective, sensitive, and
accurate rapid diagnostic tests would enable the malaria
diagnosis to be better handled.
The new rapid malaria diagnostic tests are based on im-
munochromatographic techniques using conjugated mono-
clonal antibodies as infection indicators. The detected anti-
gens are preferably those present in all forms of the parasite
(either sexual or asexual), such as histidine rich protein II
(HRPII), lactate dehydrogenase (LDH), and aldolase.
The World Health Organization (WHO) establishes that
RDT sensitivity must be close to 100% in parasitemias over
100 parasites/µl[ 13, 14]. The RDTs that are currently on the
marketcandetectparasitemiasover100parasites/µlin15–20
minutes without the need for equipment, which simpliﬁes
the procedure with respect to other diagnostic methods
[6, 7].
Malaria is one of the most important public health prob-
lems in Equatorial Guinea, and it is responsible for the high
morbidity and mortality rates, particularly among the under
ﬁve-year-old children and the pregnant women [15–18].
In the last 5 years, two important malaria control projects
have been developed in Equatorial Guinea mainly focused
on the indoor spraying with residual eﬀect insecticides
(IRS) [16, 19], but also seeking to improve the diagnostic
quality of malaria in health centers by means of introducing
RDTs.
This study aims to assess the sensitivity and speciﬁcity
of a rapid diagnostic test, which is going to be introduced
in Equatorial Guinea to diagnose malaria, compared to
microscopy (diagnostic reference test or “gold standard”).
2.MaterialandMethods
2.1. Study Design. The study was carried out in the Malaria
Reference Laboratory (MRL) located on the island of
Bioko, Equatorial Guinea. Malaria in Equatorial Guinea is
hyperholoendemic [15]. Entomological studies conducted
on the island of Bioko have shown high transmission values
for the main vector species: 242.7–281 infective bites per year
for Anopheles gambiae s.s. and 317–787.6 for An. funestus s.l.
[17, 18]. In the last years, a sustained decrease of malaria
transmission on the island of Bioko has been observed due
to the implementation of a major malaria control project
[16, 19]. Previous papers have deeply described both the
geographical characteristics of this island and its malaria
transmission pattern [15, 16].
Research methodology was in accordance with the Stan-
dards for Reporting Diagnostic Accuracy (STARD) initiative
guidelines to assess the validity of diagnostic tests [20].
During the months of September and October 2007 (end
of the local rainy season), under ﬁve-year-old children
suspected of suﬀering from malaria and referred to the MRL
by their physicians were consecutively enrolled until the
established sample was reached. Posttreatment monitoring
and relapsing cases were not included in the analysis.
The legal guardians of the recruited children were
informed about the study, and after that their consent to
participate was requested. The test outcome was shared with
the physicians to help with the ﬁnal diagnosis. The study
was approved by the National Malaria Control Programme
authorities (Ministry of Health and Social Welfare), and no
bioethical impediments were found to disallow the study.
The sample size was calculated with an alpha error of
5% and a statistical power of 80%. The estimated prevalence
was established from the frequency of positive diagnostics
by microscopy in the MRL in 2006: 31% by Plasmodium
spp. of which more than 90% corresponded to P. falciparum
infections. A 10% of children were added to the sample size
to oﬀset drop outs or errors. The estimated initial sample
was 360 children, which was subsequently increased to 400
children.
2.2. Blood Samples Collection and Analysing. A blood sample
was taken from the ﬁnger of the under ﬁve-year-old children
recruited in the study. Giemsa-stained thick and thin blood
ﬁlms were performed for each sample. Parasite density
(parasites/µl of blood) was established by comparing the
ratio of counted parasites within a hundred microscopic
ﬁelds against counted white blood cells (WBCs). Two lab
technicians using a double-blind procedure performed the
microscopic diagnosis. Regarding diagnostic result, it was
considered a discordant result; there is no concordance on
the species diﬀerentiation, either simple or mixed infections,
and/or there was a diﬀerence of more than 25% on the
parasite count. In that case, a third technician was involved
in the diagnosis. When the discrepancy criteria kept on, the
three lab technicians reassessed the sample and settled a ﬁnal
diagnosis.
The diagnostic capacity (sensitivity and speciﬁcity) of
the lab technicians was previously certiﬁed by means of
reading a slide bank (20 positives for Plasmodium spp.
and 10 negatives for plasmodia) that had previously been
validated by experts [21]. After gathering the blood sample
to perform the microscopic diagnosis, 5µlw e r ec o l l e c t e d
to carry out the rapid immunochromatographic test (ICT
Malaria Combo Cassette Test; ICT Diagnostics, Cape Town,
South Africa; http://www.ictdiagnostics.co.za). ICT Malaria
Combo Cassette Test is a rapid, in vitro diagnostic test for
the detection of circulating P. falciparum antigens (HRPII
antigen) and an antigen that is common to all four species
of malaria (aldolase antigen). HRPII is profusely expressed
on the surface of the red blood cells parasitized by P.
falciparum while aldolase is produced during the glycolytic
cycle of the parasite in all the plasmodia species. The test
uses speciﬁc monoclonal antibodies for each of HRPII and
aldolase antigens that have been immobilized across the test
strip. A procedural control line is also immobilized across
the test strip and will always appear if the test has been
correctly performed. The test is positive when 2 or 3 lines
appear in the test window. As long as the control line appearsMalaria Research and Treatment 3
the following represents positive test results: P. falciparum
positive: a control line and one upper test line (HRPII
antigen); P. falciparum infection or a mixed infection (P.
vivax., P. malariae,a n dP. ovale): a control line and 2 test
lines (HRPII and aldolase antigens); P. vivax., P. malariae,
and P. ovale or a mixed infection of all three: a control line
and one lower test line (aldolase antigen). The procedure
followed and the reagents used for the reading were those
recommended and provided by the test manufacturer.
2.3. Statistical Analysis. The data was analysed using Stata
v. 8.2 software (Stata Corporation, College Station Texas,
2007). Taking the microscopy as the diagnostic reference
test (“gold standard”), the sensitivity and speciﬁcity of the
RDT by detected parasitemia ranks were calculated in order
to determine its validity. In addition, the reliability of the
rapid test when detecting P. falciparum was determined by
means of calculating the positive predictive value (PPV), the
negative predictive value (NPV), the area under the receiver
operator characteristic curve (AUC), and the likelihood
ratios.
TheCohen’skappatestwasusedtoanalysetheagreement
between the two diagnostic tests. Finally, the Spearman
correlation was established between the parasitemia and the
reading of the intensity of the RDT diagnostic band. All
estimated parameters are detailed with a 95% Conﬁdence
Interval (CI) unless otherwise stated.
3. Results
The sensitivity of the diagnosis in the reading of the slide
bank by the lab technicians that performed the study was
100% (conﬁdence interval, CI90%:86%—not applicable
(NA)) and the speciﬁcity 100% (CI90%:74%—NA). The
accuracy percentage to determine the species ranged from
47% to 76% and from 43% to 68% for quantifying the
parasitemia.
A total of 400 samples, 207 of which were from males
(51.7%) and 193 from females (48.3%), were analysed. The
average age of the total of the sample was 1.8 year old
(standard deviation, SD = 1.3 year old). The average packed
cell volume (PCV) was 32.2% (SD = 4.9%).
Out of the total samples analysed by microscopy, 270
(67.5%) were negative for Plasmodium spp., 66 (16.5%) pos-
itive for P. falciparum, 30 (7.5%) P. falciparum + P. malariae,
20 (5.0%) P. falciparum + P. ovale, 12 (3.0%) P. malariae,
and 2 (0.5%) P. ovale. The median of the parasitemia was
5,360 parasites per µl of total blood (Interquartile range (IR):
[80–11,160] parasites per µl of total blood). P. falciparum
gametocytes were observed in 10% of the positive samples
(13/130) and schizonts in 6.9% (9/130).
The ICT test diagnosed 245 (61.25%) samples as neg-
ative, 117 (29.25%) as mixed infections that contained P.
falciparum, 21 (5.25%) as infection by other plasmodia
species, and 17 (4.25%) as simple infection by P. falciparum.
ThecontrolbandofalltheICTtestsperformedindicated
thatthetesthadbeenperformedcorrectly.Thereadingofthe
band was considered visible in 58.7% of the total of positive
samples (91/155), very weak in 20.7% (32/155), weak in
13.5% (21/155), and very visible in 7.1% (11/155).
The sensitivity of the ICT test to detect Plasmodium
spp. compared to microscopy was 81.5% (CI95% = 73.8%–
87.8%) and the speciﬁcity 81.9% (CI95% = 76.7%–86.3%).
The AUC was 0.82 (CI95% = 0.78–0.86). The PPV was
68.5% (CI95% = 60.4%–75.6%) and the NPV 90.2%
(CI95% = 85.8%–93.6%). On the other hand, the LR+
was 4.49 (CI95% = 3.44–5.86) and the LR− 0.27 (CI95% =
0.16–0.33).
In order to analyse the reliability of the RDT when
detecting P. falciparum monoinfection, the mixed infections
diagnosed by microscopy were not taken into account while
in the ICT test, both the P. falciparum monoinfection
(HRPII-speciﬁc antigen) and the mixed infections were
included in the analysis. Only 5 out of 66 (7,6%) P. fal-
ciparum monoinfections diagnosed by microscopy were
identiﬁed as such by the ICT test.
The sensitivity of the ICT test to detect P. falcipar-
um monoinfection compared to microscopy was 69.7%
(CI95%=57.1%–80.4%)andthespeciﬁcity73.7%(CI95%=
68.6%–78.3%). The AUC was 0.72 (CI95%=0.66%–0.78%).
Nonetheless, when P. falciparum monoinfections that exclu-
sively expressed the HRPII antigen were considered, the
sensitivity fell to 17%.
The PPV was 34.3% (CI95%=26.3%–43.0%) and the
NPV 92.5% (CI95%=88.6%–95.3%). The LR+ was 2.65
(CI95%=2.08–3.36)andtheLR−0.41(CI95%=0.28–0.59).
Alltheabovevaluesdiﬀeredwhentheyareanalysedusing
parasitemia ranges (see Table 1).
Both tests agreed in their diagnostics 67.2% of the time
(with the expected coincidence being equal to 54.7%). The
concordance measured by the Cohen’s kappa test was 0.28
(se: 0.04).
The intensity of the reading band of the ICT test was
directly correlated with the intensity of the parasitemia
observed by microscopy (Spearman rho=0.73).
4. Discussion
The sensitivity of the ICT Malaria Combo Cassette Test
to detect Plasmodium spp. was similar to that observed in
other studies with RDT based on the detection of the HRPII
antigen. Moreover the speciﬁcity of obtained values ranked
slightly under the published data where it was usually over
90% [6–8, 22–25], although this result should be considered
with caution due to limited sample size. The ICT Combo
Cassette Test was tested in the Round 1 WHO Product Testing
of RDTs (2008) performing a detection rate against wild type
P. falciparum samples (n = 79) of 86.08% at low parasite
density (<200 parasites/µl) and 100% at higher parasitemias
(2000–5000 parasites/µl) while it only identiﬁed 15 out of
20 (75%) cultured P. falciparum lines when parasitemia was
below 200 parasites/µl[ 26]. Nonetheless, the fact that the
RDT type, target population, and epidemiological context
inﬂuence the feasibility and reliability of these immunochro-
matographic tests must be taken into account. In addition,
exposure to high temperatures during transport and storage,
commonplace in tropical countries, can degrade the tests4 Malaria Research and Treatment
Table 1: Sensitivity and speciﬁcity of the ICT test compared to microscopy by Plasmodium falciparum monoinfection and parasitemia
ranges.
Parasites/µlN ∗ Sn Sp PPV NPV LR+ LR− AUC
<101 27 33.3
(54.0–16.5)#
88.8
(92.2–84.4)
22.5
(38.5–10.8)
93.2
(95.9–89.4)
2.9
(5.6–1.6)
0.7
(0.9–0.6)
0.6
(0.7–0.5)
101–500 4 50.0
(93.2–6.7)
88.3
(83.9–91.8)
5.8
(19.7–0.7)
99.2
(99.9–97.1)
4.3
(12–1.5)
0.5
(1.5–0.2)
0.7
(0.9–0.4)
>500 35 100.0
(100.0–90.0)
73.8
(78.5–68.7)
29.2
(38.2–21.2)
100.0
(100.0–98.5)
3.8
(4.6–3.2) 0 0.8
(0.9–0.8)
Sn: sensitivity.
Sp:speciﬁcity.
PPV:positive predictive value.
NPV:negative predictive value.
LR+:Likelihood Ratio of positive test.
LR−:Likelihood Ratio of negative test.
AUC:Area Under the Receiver Operator Characteristic Curve.
∗Number of individuals with monoinfection by Plasmodium falciparumin each parasitemia group.
#All values in brackets indicate 95% Conﬁdence Intervals.
and bias the results [27]. In the present assessment, the RDT
storageandtransportconditionswerecontrolledthroughout
the study, and the storage temperature recommended by the
manufacturer was not exceeded.
The ICT rapid test stood out for its NPV, in other words,
for its greater capacity to detect precisely the absence of
malaria while the PPV was lower, particularly for the speciﬁc
diagnostics, which demonstrated the weakness of the test to
diagnose positive cases by microscopy.
The diagnostic capacity of the ICT test to detect P.
falciparum was marked by the presence of false positives
(65.7% compared to 31.6% false positive in the detection
of Plasmodium spp.) but it does not signiﬁcantly bias the
assessment of the tests in clinical practice [28, 29]. In
extensive reviews on malaria RDT, these false positives have
been linked with individuals that had been recently treated
with antimalaria drugs and with the presence of the serum
rheumatoid factor [6, 7] .I no u rs t u d y ,i ti sl i k e l yt h a tm a n y
of the children had received treatment in the days prior
to the sample collection without being reported by their
guardians, and therefore they presented residual circulating
HRPII antigens. On the other hand, mistakes in microscopy
slide reading, although unlikely due to the participation of
three trained microscopists, can not be excluded.
False positives could also be attributed to chronic
infections [30]. Even expert lab technicians ﬁnd it diﬃcult
to detect chronic infections in high endemic zones, charac-
terised by low parasitemias and few or nonexistent clinical
manifestations [31]. However, this fact was unlikely in this
study since children suspected of suﬀering from malaria
(with clinical criteria) were only recruited.
In any case, it has been indicated that the detection and
treatment of these cases do not have great clinical relevance,
albeit they are important from the transmission point of
view as the majority of them present gametocytemia [32].
ICT tests are not able to discriminate persisting asexual
parasitemia from gametocytemia. The detection of residual
HRPII antigen detection could be an advantage as it widens
the diagnostic opportunities of ﬂuctuant parasitemias.
In the same way as in other studies where the parasitemia
subgroups have been analysed, variations were observed in
the feasibility and reliability of the test to detect P. falciparum
according to parasitemia [6, 7].
Particularly noteworthy is that the ICT test was only
capable of identifying 7.6% of the P. falciparum monoin-
fections diagnosed by microscopy. Therefore, the antigens
present in all the plasmodium species seemed to play a
greaterroleinthediagnosticsthanthespeciﬁcHRPIIantigen
of the P. falciparum. Subsequent controlled studies would
be necessary to assess properly these facts. Nonetheless, it
has been put forward that the diversity of the genes that
codify the HRPII antigens in P. falciparum from diﬀerent
geographical areas may explain the disparity in the results
obtained in the diﬀerent ﬁeld tests [33]. However, the
sequences that codify the aldolase are well conserved in the
diﬀerent plasmodium populations [34].
Bearing in mind the cost that the ICT tests can represent
for the national health system of Equatorial Guinea, its cost
eﬀectiveness needs to be carefully considered [35]. Many
of the current RDT have been shown to have a lower
cost per unit than a three-day cycle with the majority of
the artemisinin-based combination therapies (ACTs) [36].
The introduction of the ACTs in the country probably will
increase the cost eﬀectiveness of the rapid tests if the over-
prescribing of these drugs is reduced [37].
As has already been discussed, the malaria transmission
levels condition the diagnostic reliability using RDT. On
the island of Bioko, the IRS-based control programme and
growing urban development, among other factors, have
managed to signiﬁcantly reduce the prevalence of the disease
[16]. Thus, when the malaria transmission levels are low or
moderate, the RDTs could be more cost eﬀective than low-
quality microscopy, usual in resource-poor health systems
[38]. In high prevalence areas (over 70%), the empirical
treatment is the ﬁrst option in cost eﬀectiveness terms [39].
Models developed in conjunction with the WHO con-
sider cost eﬀective the RDT in comparison with the
presumptive treatment up to high prevalence values ofMalaria Research and Treatment 5
P. falciparum infection. This model is subordinated to the
prescribers basing their therapy decisions in line with the
testoutcome[40].Therefore,adherencetothediagnostictest
outcome determines the cost eﬀectiveness of the RDT, and it
must condition the health policies that regulate its use.
The WHO recommends that all patients are diagnosed
as suﬀering from malaria by means of a test that shows the
parasite infection, with the possible exception of children
in high epidemic areas where the high mortality of the
badly diagnosed cases does not allow the weaknesses of the
diagnosticteststobeassumed[41,42].Thislastpoint,which
directly aﬀects the cohort studied in this analysis, would
clearly limit the use of the RDT and the strict following of
their outcomes to decide the treatment for the under ﬁve
year-old children.
5. Conclusions
In Equatorial Guinea, the rapid ICT Malaria Pf. Pv. Po.
Pm Combo Cassette Test has proven to be an acceptable
test to detect high P. falciparum parasitemias in peripheral
blood under experimental conditions. Therefore, it can be
used as a support tool to diagnose malaria in resource-poor
health care settings, where quality microscopy diagnosis is
either not present or not guaranteed. However, the existing
shortcomings regarding its upkeep and handling should be
taken into account. On the other hand, the decrease of
sensitivity at medium and low parasitemias hampers that
ICT can replace properly performed microscopy diagnosis
at present in under ﬁve-year-old children, the most aﬀected
by malaria in a high prevalence country as Equatorial
Guinea.
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